PTK2B and breast cancer: Alpha-naphthoflavone (ANF) decreased the phosphorylation of PyK2 in MCF-7 cells, and the combination of doxorubicin and ANF reduced breast cancer volume compared with a single treatment of doxorubicin or ANF in breast cancer-xenografted mice [95].